Physician

Sunil Adige, M.D.

According to 2025 Medicare claims, Sunil Adige, M.D. (NPI: 1497140156) practices hematology/oncology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is MEDICAL FACULTY ASSOCIATES, INC (NPI: 1417990581; TIN: 522220700) and primary practice location at 20037-3201. Adige is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Adige's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 209 traditional Medicare patients, billed 15,712 HCPCS/CPT codes, and received $330,514 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 645 prescription claims across 163 beneficiaries totaling $545,261 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $6,024 to $545,261. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.